These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12494248)

  • 1. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
    Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
    Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    Int J Cancer; 2006 Jun; 118(12):3084-8. PubMed ID: 16425285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
    Fujii R; Seshimo A; Kameoka S
    Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
    Hahnvajanawong C; Chaiyagool J; Seubwai W; Bhudhisawasdi V; Namwat N; Khuntikeo N; Sripa B; Pugkhem A; Tassaneeyakul W
    World J Gastroenterol; 2012 Aug; 18(30):3955-61. PubMed ID: 22912546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma.
    Furuse H; Hirano Y; Harada M; Ming LH; Aoki T; Kurita Y; Mugiya S; Ushiyama T; Ozono S
    Anticancer Res; 2009 Apr; 29(4):1001-8. PubMed ID: 19414338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Sasaki H; Saito T
    Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Orotate phosphoribosyl transferase in bladder cancer].
    Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: relationship between histological parameters and chemosensitivity to 5-fluorouracil.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Eur Urol; 2003 Jan; 43(1):45-51; discussion 51-2. PubMed ID: 12507543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
    Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
    Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy.
    Ishikawa M; Miyauchi T; Kashiwagi Y
    BMC Cancer; 2008 Jul; 8():188. PubMed ID: 18597678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between clinical pathologic factors and activity of 5-FU-metabolizing enzymes in colorectal cancer.
    Yamada T; Tanaka N; Yokoi K; Seya T; Kanazawa Y; Koizumi M; Ohaki Y; Tajiri T
    J Nippon Med Sch; 2008 Feb; 75(1):23-7. PubMed ID: 18360075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer.
    Ochiai T; Umeki M; Miyake H; Iida T; Okumura M; Ohno K; Sakamoto M; Miyoshi N; Takahashi M; Tsumura H; Tokunaga Y; Naitou H; Fukui T
    Oncol Rep; 2014 Sep; 32(3):887-92. PubMed ID: 24994673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of dihydropyrimidine dehydrogenase, orotate phosphoribosyl transferase and thymidylate synthase in patients with primary colorectal cancer, and associations with site of first metastasis.
    Akagi Y; Kinugasa T; Mizobe T; Kawahara A; Kage M; Shirouzu K
    Anticancer Res; 2012 Jun; 32(6):2277-82. PubMed ID: 22641663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
    Ikeguchi M; Makino M; Kaibara N
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.